These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36821457)

  • 1. Intestinal microbiota in biliary diseases.
    Xia Q; Liu Q; Ma X
    Curr Opin Gastroenterol; 2023 Mar; 39(2):95-102. PubMed ID: 36821457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
    Mattner J
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.
    Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E
    J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gut microbial influence on cholestatic liver disease.
    Kummen M; Hov JR
    Liver Int; 2019 Jul; 39(7):1186-1196. PubMed ID: 31125502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of gut microbiota in autoimmune liver diseases.
    Qian Q; He W; Tang R; Ma X
    Minerva Gastroenterol (Torino); 2023 Mar; 69(1):95-106. PubMed ID: 33793160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy.
    Bozward AG; Ronca V; Osei-Bordom D; Oo YH
    Front Immunol; 2021; 12():711217. PubMed ID: 34512631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring Advanced Therapies for Primary Biliary Cholangitis: Insights from the Gut Microbiota-Bile Acid-Immunity Network.
    Guo Z; He K; Pang K; Yang D; Lyu C; Xu H; Wu D
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.
    Sarcognato S; Sacchi D; Grillo F; Cazzagon N; Fabris L; Cadamuro M; Cataldo I; Covelli C; Mangia A; Guido M
    Pathologica; 2021 Jun; 113(3):170-184. PubMed ID: 34294935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts.
    Özdirik B; Schnabl B
    Cell Mol Gastroenterol Hepatol; 2024; 17(3):423-438. PubMed ID: 38109970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.
    Li Y; Tang R; Leung PSC; Gershwin ME; Ma X
    Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies-A Critical Overview.
    Kasztelan-Szczerbinska B; Rycyk-Bojarzynska A; Szczerbinska A; Cichoz-Lach H
    Nutrients; 2023 Feb; 15(3):. PubMed ID: 36771465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.
    Bell LN; Wulff J; Comerford M; Vuppalanchi R; Chalasani N
    Liver Int; 2015 Jan; 35(1):263-74. PubMed ID: 25181933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC.
    Jiang H; Yu Y; Hu X; Du B; Shao Y; Wang F; Chen L; Yan R; Li L; Lv L
    Gut Microbes; 2024; 16(1):2383353. PubMed ID: 39105259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting.
    Bosch DE; Zen Y; Boukhar SA; Liu Y; Cheng L; Yeh MM
    Virchows Arch; 2021 Dec; 479(6):1131-1143. PubMed ID: 34414507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal microbiota and biliary system diseases.
    Wang H; Gong J; Chen J; Zhang W; Sun Y; Sun D
    Front Cell Infect Microbiol; 2024; 14():1362933. PubMed ID: 38558851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
    Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
    Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
    Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota in Primary Sclerosing Cholangitis: From Prognostic Role to Therapeutic Implications.
    Maccauro V; Fianchi F; Gasbarrini A; Ponziani FR
    Dig Dis; 2024; 42(4):369-379. PubMed ID: 38527453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value.
    Li ZJ; Gou HZ; Zhang YL; Song XJ; Zhang L
    World J Gastroenterol; 2022 Nov; 28(44):6213-6229. PubMed ID: 36504550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.